Searched for
BIOLOGICS DIVISION PERFORMANCE
Samsung’s $416,000 chip worker bonuses may reshape labour battles in South KoreaSamsung Electronics has agreed to a significant bonus deal with its union, a move that could reshape wage bargaining in South Korea. Memory...- ET Exclusive | Biologics merger with Biocon most value-accretive option: Kiran Mazumdar ShawBiocon is fully integrating Biocon Biologics, valuing its biosimilar business at $5.5 billion. This move removes debt concerns and improves...
- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Syngene International shares slump 10% after Q4 profit dips despite revenue growthSyngene International's shares plummeted 10% following a reported 3% year-on-year decline in consolidated net profit for Q4 FY25, despite a...
- Biocon Biologics looks to trim $300 million debt in 1 yearBiocon Biologics plans to reduce its acquisition debt by $300 million over the next year. The company recently refinanced $1.1 billion in d...
- This agri stock gave 85% returns last year; is Dhanuka Agritech a good buy now? Know what analysts sayDhanuka Agritech: The company’s product range spans insecticides, fungicides and herbicides, distributed nationwide, with three manufacturi...
- Biocon denies plans to sell $1.5 billion generic API businessBiocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valu...
- Syngene International Q1 Results: Net profit jumps 26% to Rs 93 croreThe first quarter revenue from operations rose 26% YoY to Rs. 832 crore. The earnings before interest, tax, depreciation and ammortisation ...
- Syngene International Q4 Results: Net profit jumps 21% to YoY Rs 179 croreHunt said the manufacturing services had a particularly strong year, led by the commercial-scale biologics manufacturing business, which ha...
- Syngene reports Rs 102 crore net profit in Q2FY23The company reported net profit of Rs 102 crore during Q2FY23, compared to Rs 67 crore during the corresponding quarter of the previous yea...
- Worried about Afghan terror, Russia-led military alliance forms a new unit to counter biological weaponsOperational groups of the Joint Staff and the CSTO Secretariat, the formation of special forces from among special units of the internal af...
- Jonathan Hunt on growth triggers which led to upgrade of Syngene sales guidance“ Syngene has signed a 10-year strategic deal with Zoetis in animal health: It was a real piece of innovation from Zoetis and we are deligh...
- Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 croreThe earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...
- Biocon Q2 Results: Profit dips 18% to Rs 138 croreThe country’s largest biopharmaceutical company’s net profits before exceptional items grew by 11% to Rs 188 crore in the quarter, it repor...
- Billion dollar target for biologics biz by FY22 unrealistic, but we would soon return to high growth trajectory: Kiran Mazumdar Shaw“There is a marginal decline in biosimilar segment but we expect to see the business pick up in Q1 of FY22.”
- Temasek, TrueNorth-CPPIB seek to invest in Biocon BiologicsEye minority stake in Biocon Biologics; unit may be valued at $4 billion, higher than the market cap of Biocon.
- Men vs women: It's 2017 - and guess who does more household chores?Gender becomes the biggest predictor of who will do what around the house when couples are in their forties.
- Night shift workers at increased risk for car crashesNight shift workers may be at an increased risk for drowsy driving crashes because of disruption to their sleep-wake cycles and insufficien...
- Novartis posts 10 pc drop in Q2 net profitNovartis AG posted 10 percent drop in second quarter net profit due to shifts in currency values and higher financing costs, but said under...
- DuPont to set up Rs 100 cr R&D centreDuPont India, subsidiary of the US-based $29 billion EI du Pont de Nemours, is setting up a research and development centre in Hyderabad at...
Load More
